ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its … – SunHerald.com
ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its …SunHerald.comToday NHL is frequently treated with the anticancer antibody, rituximab (Rituxan®), and/or with chemotherapy. The novel agent IMGN529, a TAP compound, conta…
